Tirzepatide

Dual Agonist · GLP-1 + GIP

Tirzepatide is a synthetic 39-amino-acid peptide modified with a fatty-acid chain for extended release. As a dual agonist of GIP and GLP-1, it delivers up to 20.9% total body-weight loss — not just radical aesthetic reduction, but a complete metabolic reset. The GIP component is what separates it from the previous generation: better craving control, fewer GI side effects, and superior nutrient partitioning to muscle.

• Accelerated body recomposition — destroys stubborn fat deposits while maintaining a highly efficient metabolic environment
• Insulin resistance reversal — restores insulin sensitivity to optimal levels, completely stabilizing blood sugar and eliminating energy crashes
• Complete food-noise silence — shuts off the mental urgency and psychological drive to eat from boredom or emotional stress
• Systemic inflammation reduction — by lowering glucose spikes and visceral adipose tissue, inflammatory markers (C-Reactive Protein) drop dramatically, protecting the cardiovascular system
• Superior tolerability vs. semaglutide — the GIP component actively mitigates the nausea and GI discomfort common with pure GLP-1 treatment